Alzheimer's disease is a progressive and irreversible brain disorder that gradually impairs memory, thinking abilities, and overall cognitive function. It is the most common form of dementia, affecting millions of people worldwide. This introduction ...
Alzheimer's disease is a progressive neurological disorder that affects millions of people worldwide. It is characterized by the gradual loss of cognitive function, including memory, language, and reasoning skills. While the exact cause of Alzheimer' ...
The new cell model of the most common form of Alzheimer’s points to molecular causes, drug target Harvard Medical School geneticists has created a new model-in-a-dish of sporadic Alzheimer’s disease, which accounts for more than 90 percent of Alz ...
Researchers have found that the proteins that control the progression of Alzheimer’s are linked in a pathway, and that drugs targeting this pathway may be a way of treating the disease, which affects 40 million people worldwide. The findings are publ ...
Neurotrope, Inc. announced that the last patient has been dosed in its Phase 2a clinical trial of Bryostatin-1 for the treatment of patients with Alzheimer's disease (AD). The trial is being conducted under an Investigational New Drug (IND) applicati ...
Scientists have linked a new protein to Alzheimer's disease, different from the amyloid and tau that make up the sticky brain plaques and tangles long known to be its hallmarks. The discovery could give a new target for developing drugs and other ...